| # | Drug | Count |
|---|---|---|
| 0 | DENOSUMAB | 412 |
| 1 | ADALIMUMAB | 180 |
| 2 | ALENDRONATE SODIUM | 163 |
| 3 | ETANERCEPT | 100 |
| 4 | RISANKIZUMAB-RZAA | 76 |
| 5 | UPADACITINIB | 74 |
| 6 | ERGOCALCIFEROL | 66 |
| 7 | METHOTREXATE | 61 |
| 8 | METHOTREXATE SODIUM | 60 |
| 9 | LEVOTHYROXINE SODIUM | 59 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 39 | 0.0141 |
| 1 | HALOBETASOL PROPIONATE AND TAZAROTENE | 2 | 0.0101 |
| 2 | MENADIONE | 1 | 0.0072 |
| 3 | INFLIXIMAB-DYYB | 20 | 0.0058 |
| 4 | LEVOKETOCONAZOLE | 3 | 0.0040 |
| 5 | 1169 HYDROGEN PEROXIDE SPRAY | 1 | 0.0032 |
| 6 | HYDROGEN PEROXIDE | 1 | 0.0030 |
| 7 | PAMIDRONATE DISODIUM | 10 | 0.0029 |
| 8 | LEVORPHANOL TARTRATE | 1 | 0.0027 |
| 9 | DICLOFENAC SODIUM/MISOPROSTOL | 1 | 0.0023 |
| # | Drug class | Count |
|---|---|---|
| 0 | RANK Ligand Inhibitor [EPC] | 412 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 136 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 92 |
| 3 | Vitamin D [EPC] | 82 |
| 4 | Corticosteroid [EPC] | 77 |
| 5 | Janus Kinase Inhibitor [EPC] | 75 |
| 6 | Vitamin C [EPC] | 69 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 60 |
| 8 | Vitamin B12 [EPC] | 50 |
| 9 | Calcium [EPC] | 43 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cortisol Synthesis Inhibitor [EPC] | 3 | 0.0040 |
| 1 | RANK Ligand Inhibitor [EPC] | 412 | 0.0020 |
| 2 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 3 | Aryl Hydrocarbon Receptor Agonist [EPC] | 1 | 0.0005 |
| 4 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 5 | Janus Kinase Inhibitor [EPC] | 75 | 0.0005 |
| 6 | Blood Viscosity Reducer [EPC] | 2 | 0.0005 |
| 7 | mu-Opioid Receptor Agonist [EPC] | 1 | 0.0003 |
| 8 | Calcitonin [EPC] | 1 | 0.0003 |
| 9 | Chloride Channel Activator [EPC] | 3 | 0.0003 |